BDP-12(Ampalex) chemical structure
Chemical structureResearch use only
CAT. NO. DC5075Featured

BDP-12(Ampalex)

Pack Sizes & Prices

TotalUS$300
We match the best price and quality on market.
Product overview

Description & Application

Ampalex (Ampakine CX516; CX516; BDP 12) is an ampakine and nootropic that acts as an AMPA receptor positive allosteric modulator as a treatment for Alzheimer's disease, schizophrenia and mild cognitive impairment (MCI).

ParameterValue
Chemical NameAmpalex
CAS No.154235-83-3
SynonymsPiperidin-1-yl(quinoxalin-6-yl)methanone;1-(Quinoxalin-6-ylcarbonyl)piperidine;Piperidin-1-yl-quinoxalin-6-ylmethanone;Ampalex;ABT-224;Ampakine CX516;BDP 12;CX516;CX-516;PIPERIDINE, 1-(6-QUINOXALINYLCARBONYL)-;1-Piperidinyl-6-quinoxalinyl-methanone;6-(Piperidin-1-ylcarbonyl)quinoxaline;AMpalex (CX-516);SPD-420, BDP-12, CX-516, AMpalex;1-(6-Quinoxalinylcarbonyl)piperidine;1-Piperidinyl-6-quinoxalinylMethanone;BDP-12;BDP-12;;CX 516;Ampalex, >=98%;6-(piperidine-1-carbonyl)quinoxaline;1-piperidyl(quinoxalin-6-yl)methanone;Z5QU38B4V9;Piperidin-1-yl-quinoxalin-6-yl-methanone;1-(6-quinoxalinylcarbonyl)-Piperidine;PubChem
FormulaC14H15N3O
M.Wt241.2884
SMILESO=C(C1C([H])=C([H])C2C(C=1[H])=NC([H])=C([H])N=2)N1C([H])([H])C([H])([H])C([H])([H])C([H])([H])C1([H])[H]
Purity>98%
Storage2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO

Biological Activity

Ampalex (Ampakine CX516; CX516; BDP 12) is an ampakine and nootropic that acts as an AMPA receptor positive allosteric modulator as a treatment for Alzheimer's disease, schizophrenia and mild cognitive impairment (MCI).

In Vitro

No in vitro data are provided in the current product source. Contact us for further information.

In Vivo

No in vivo data are provided in the current product source. Contact us for further information.

References & source

DC Chemicals original product information

Published experimental findings depend on the model and assay conditions. They do not guarantee equivalent performance in every application. For laboratory research use only.

Product documentation

View online datasheetRequest COA / MSDS

Refer to the certificate supplied with your lot for batch-specific release results.

Handling guide

2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO

Solution calculator

Related research products

MDL 29951 chemical structureDC7194

MDL 29951

MDL-29951 is a novel glycine antagonist of NMDA receptor activation, with Ki of 0.14 μM for [3H]glycine binding in vitro and in vivo.

View activity & prices
CIQ chemical structureDC8156

CIQ

CIQ is a subunit-selective potentiator of NMDA receptors containing the NR2C or NR2D subunit. IC50 value: 2.7 μM (EC50, for NR2C) and 2.8 μM (EC50, NR2D)Target: NMDA receptorCIQ increases channel opening frequency of…

View activity & prices
Perampanel(E2007） chemical structureDC7226

Perampanel(E2007）

Perampanel(E2007; ER 155055-90) is a selective noncompetitive AMPA-type glutamate receptor antagonist which has demonstrated anticonvulsant activity in experimental seizure models and antiepileptic activity in clinical…

View activity & prices
PEPA chemical structureDC7989

PEPA

PEPA is an allosteric modulator of AMPA receptors; binds to the GluA2o and GluA3o LBDs and can be utilized as an indicator of AMPA receptor heterogeneity.

View activity & prices
DNQX chemical structureDC10672

DNQX

DNQX is a AMPA receptor antagonists.target: AMPA receptorIn vitro: DNQX, added 2 h after cell plating, induces a dose-dependent neurotoxicity.

View activity & prices
DNQX disodium salt chemical structureDC10673

DNQX disodium salt

DNQX (FG 9041) disodium salt, a quinoxaline derivative, is a selective, potent competitive non-NMDA glutamate receptor antagonist (IC50s = 0.5, 2 and 40 μM for AMPA, kainate and NMDA receptors, respectively)[1].

View activity & prices

Cart

Request quotation